Announcements

Intimation of decision taken at the Board Meeting held on January 28, 2022 to approve the following Special Purpose Interim Consolidated financial statements – For the period 1st April to 30th November 2021 and for the stub period 2nd September to 30th November 2021. Approved the Restated financial statements for the stub period 2nd September to 30th November 2021.The Board has appointed Mr. Sachin Salvi, presently working as Senior Vice-President-Finance, as Chief Financial Officer of the Company effective from today, 28^th January 2022

Intimation of decision taken at the Board Meeting held on January 10, 2022 for approval for sharing financials statements for the period 1st April to 30th September 2021, For the period 1st April to 1st September 2021, For the period 2nd September to 30th September 2021 with API Holdings Limited.

Intimation of decision taken at the Board Meeting held on December 16, 2021 for approval for sharing certain financial information (Stand-alone and Consolidated) of the Company with API Holdings Limited .

Intimation that Trading Window shall remain closed for Directors, Designated Employees and Connected Persons with effect from 1^st January, 2022 and will be reopened after 48 hours of date of announcement / declaration of Unaudited Financial Results for the Quarter/Nine Months ended December 31, 2021.

Intimation of decision taken at the Board Meeting held on November 13, 2021- (i) approval of the Unaudited Financial Results (both Stand-alone and Consolidated) for the quarter /half year ended on 30-09-2021.

Intimation about Board Meeting scheduled to be held on Saturday, November 13, 2021, inter alia, to consider and approve the unaudited financial results (both Stand-alone and Consolidated) for the quarter / half year ended 30th September 2021

Intimation regarding allotment of 28913 Equity Shares to 158 eligible employees after obtaining required approvals from Stock Exchanges.

The Board of Directors of the Company, at their meeting held on 27th October 2021 has-

1)  Approved the Audited Special Purpose Consolidated financial statements of the Company as on 30^th June 2021, to be included in the DRHP of API Holdings Ltd., who are holding company of Docon Technologies Limited, who are our holding company.

2) Noted the Management Accounts of the Company (unaudited, not reviewed) as on 30^th September 2021 which would be shared with API Holdings Limited and their merchant bankers to give them comfort with respect to their DRHP. This will not be published or shared with any other individual/entity as it might be considered as unpublished price sensitive information.

3)  Approved the proposal, based on the recommendation of the Audit Committee, to enter into an agreement for outsourcing the processing of samples and generating report, with API Holdings Ltd., who are a Related Party under statutory provisions.

Intimation that Trading Window shall remain closed for Directors, Designated Employees and Connected Persons with effect from 1^st October, 2021 and will be reopened after 48 hours of date of announcement / declaration of Unaudited Financial Results for the quarter and half year ended September 30, 2021.

Intimation of decision taken at the Board Meeting held on August 12, 2021- (i) approval of the Unaudited Financial Results (both Stand-alone and Consolidated) for the quarter ended on 30-06-2021.

Intimation about Board Meeting scheduled to be held on Thursday, August 12, 2021, inter alia, to consider and approve the unaudited financial results (both Stand-alone and Consolidated) for the quarter ended 30th June 2021.

Intimation that Trading Window shall remain closed for Directors, Designated Employees and Connected Persons with effect from 1^st July, 2021 and will be reopened after 48 hours of date of announcement / declaration of Unaudited Financial Results for the Quarter ended June 30, 2021.

Intimation about execution of a share purchase agreement dated 25 June 2021 between members of the promoter and promoter group of Thyrocare Technologies Limited (“Company”) (i.e., Dr. A. Velumani, A. Sundararaju HUF, A. Velumani HUF, Amruta Velumani, Anand Velumani, A. Sundararaju, Thyrocare Properties and Infrastructure Private Limited, Pavilion Commercial Private Limited, Thyrocare Publications LLP, Sumathi Infra Project LLP and Mahima Advertising LLP) (“Sellers”) and  Docon Technologies Private Limited (“Acquirer”), the Sellers have agreed to sell to the Acquirer their entire shareholding in the Company, being equivalent to approximately 66.14% of the equity share capital of the Company (on a fully diluted basis) and being equivalent to 3,49,72,999 equity shares of the Company (collectively, the “Sale Shares”), and the Acquirer has agreed to purchase the Sale Shares from the Sellers in accordance with the share purchase agreement, completion of which is subject to certain conditions precedent  (“Share Purchase Agreement”).View Here

Intimation about (i) 21st  Annual General Meeting convened to be held on Saturday, June 26, 2021 at 3.00 P.M. through Video Conferencing (VC) / Other Audio Visual Means (OAVM) & (ii) E-voting facility available to the Shareholders prior to the AGM and during the AGM.

Intimation of decisions taken at the Board Meeting held on May 8, 2021, about approval of the Audited Financial Statements (both Stand-alone and Consolidated) for the quarter and the whole year ended 31-03-2021, Recommendation of a Dividend of Rs.15/- per share for 2020-21 and granting of Stock Options to the eligible employees of the Company for the year 2020-21.

Intimation about Board Meeting scheduled to be held on Saturday, May 8, 2021, inter alia, to consider and approve the audited financial results (both Stand-alone and Consolidated) for the year ended 31st March 2021, to consider recommending final dividend, if any, for the financial year 2020-21, and to consider granting of stock options to employees for 2020-21.

Intimation of business update about increased turnover in Q4, enhancement on the RT-PCR testing capacity of laboratories at Navi Mumbai & Gurgaon, approval of the Covid testing facility in Bangalore by NABL, completion of more than one million Covid tests as on 31-03-2021, etc. View Here

Intimation that Trading Window shall remain closed for Directors / Designated Employees / Connected Persons with effect from 1^st April, 2021, and would be re-opened after 48 hours of date of announcement / declaration of Audited Financial Results for the Year ended March 31, 2021.

Intimation about the Con-call with the representative(s) of First State Sentier, at 09.00 A.M. on Monday, March 08, 2021.

Intimation about Transcript of the Earnings Call held on Thursday, February 04, 2021 at 05.00 P.M. local time of Indian and Overseas Investors, post declaration of the Company’s Unaudited Financial Results (stand-alone & consolidated) for the Quarter / Nine Months ended 31-12-2020. Click here

Intimation about the con-calls with the representatives of the following organizations:

(i) Mirabilis Investment Trust, at 05.00 P.M. on Monday, February 15, 2021.

(ii) Arisaig Partners, at 03.00 P.M. on Friday, February 19, 2021.

Intimation about conference call for Indian and Overseas Investors to be held on Thursday, February 04, 2021 to discuss about Unaudited financial results (Stand-alone and Consolidated) for the quarter / nine months ended 31-12-2020. Click here to see the invite

Intimation of outcome of the Board Meeting held on January 30, 2021, as follows:

1) The Board approved Unaudited Financial Results (both Stand-alone and Consolidated) for the quarter / Nine Months ended 31-12-2020.

2) The Board decided to defer the question of further dividend to the next meeting.

3) With regard to appointment of new Auditors, the Board authorized Dr. A. Velumani, Chairman & Managing Director, Mr. A. Sundararaju, Executive Director & CFO and Mr. G.S. Hegde, Independent Director, to take a decision and report to the Committee / Board at the earliest.

Intimation about Board Meeting scheduled to be held on Saturday, January 30, 2021, inter alia, to consider and approve the unaudited financial results (both Stand-alone and Consolidated) for the quarter / nine months ended 31st December, 2020, to consider and decide on payment of further interim dividend, if any, for the financial year 2020-21, and to consider appointment of new auditors in the place of current auditors whose term would expire shortly.

Intimation about (1) significant business revival in Q3 of the current financial year, after business activities resumed across all states, and the growth in the non-covid business and (2) increase in volume of RT-PCR tests making us most cost effective service provider to the patients. View Here

Intimation that Trading Window shall remain closed for Directors, Designated Employees and Connected Persons with effect from 1^st January, 2021 and will be reopened after 48 hours of date of announcement / declaration of Unaudited Financial Results for the quarter / nine months ended December 31, 2020.

Intimation regarding allotment of 38054 Equity Shares to 135 eligible employees after obtaining required approvals from Stock Exchanges.

Intimation about the Con-call with the representative(s) of Grandeur Peak Global Advisors, at 10.00 A.M. on Tuesday, December 08, 2020.

Intimation about the Con-call with the representative(s) of Wellington Management Hong Kong Ltd., at 11.30 A.M. on Tuesday, November 24, 2020.

Intimation about the Con-call (Zoom Meeting) with the representative(s) of Arisaig Partners, at 05.00 P.M. today, i.e. on Tuesday, November 10, 2020.